相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CpG oligodeoxynucleotides augment antitumor efficacy of folate receptor α based DNA vaccine
Zheng Qiu et al.
ONCOLOGY REPORTS (2017)
Immunotoxin: A new tool for cancer therapy
Hossein Allahyari et al.
TUMOR BIOLOGY (2017)
Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab
Hidekazu Kuramochi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Molecular Adjuvants for DNA Vaccines
Lei Li et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2017)
Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
Wanlu Li et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2017)
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke et al.
IMMUNITY (2016)
MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model
Haihong Zhang et al.
VACCINE (2016)
Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice
Qiu Xia et al.
VACCINE (2016)
Vaccine development: From concept to early clinical testing
Anthony L. Cunningham et al.
VACCINE (2016)
MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
Johannes Betge et al.
VIRCHOWS ARCHIV (2016)
Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients
Katarzyna Jakubowska et al.
ONCOLOGY LETTERS (2016)
Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis
Jing Hua et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Irina Kareva et al.
CANCER LETTERS (2015)
Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets
David J. Graber et al.
JOURNAL OF NEUROINFLAMMATION (2015)
A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers
Massimiliano Bissa et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shabnam Shalapour et al.
NATURE (2015)
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
Jonathan Pol et al.
ONCOIMMUNOLOGY (2015)
CpG Oligonucleotides as Cancer Vaccine Adjuvants
Hidekazu Shirota et al.
VACCINES (2015)
New insights into metronomic chemotherapy-induced immunoregulation
Yi-Bin Hao et al.
CANCER LETTERS (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
Recent Developments in Preclinical DNA Vaccination
Kenji Okuda et al.
VACCINES (2014)
DNA and adenovirus tumor vaccine expressing truncated survivin generates specific immune responses and anti-tumor effects in a murine melanoma model
Haihong Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Technologies for enhanced efficacy of DNA vaccines
Fadi Saade et al.
EXPERT REVIEW OF VACCINES (2012)
The future of human DNA vaccines
Lei Li et al.
JOURNAL OF BIOTECHNOLOGY (2012)
DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model
Anna D. Kosinska et al.
JOURNAL OF VIROLOGY (2012)
A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers
Antonia Radaelli et al.
VIRUS RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
CpG oligonucleotide as an adjuvant for the treatment of prostate cancer
David M. Lubaroff et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
DNA vaccines: developing new strategies to enhance immune responses
Shaheed A. Abdulhaqq et al.
IMMUNOLOGIC RESEARCH (2008)
Tumor microenvironments, the immune system and cancer survival
RL Strausberg
GENOME BIOLOGY (2005)
Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells
D Arango et al.
BRITISH JOURNAL OF CANCER (2004)
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells
G Hartmann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
分享论文
